26.08
前日終値:
$28.04
開ける:
$28.33
24時間の取引高:
244.92K
Relative Volume:
0.28
時価総額:
$1.59B
収益:
-
当期純損益:
$-197.68M
株価収益率:
-6.9362
EPS:
-3.76
ネットキャッシュフロー:
$-158.88M
1週間 パフォーマンス:
-3.94%
1か月 パフォーマンス:
-4.99%
6か月 パフォーマンス:
+277.97%
1年 パフォーマンス:
+213.84%
Kodiak Sciences Inc Stock (KOD) Company Profile
KOD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
KOD
Kodiak Sciences Inc
|
26.08 | 1.71B | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.42 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.75 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.50 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.88 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.98 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-11 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-09-25 | アップグレード | Barclays | Underweight → Equal Weight |
| 2025-09-22 | 開始されました | Jefferies | Buy |
| 2025-08-14 | アップグレード | JP Morgan | Underweight → Neutral |
| 2024-12-09 | アップグレード | Jefferies | Hold → Buy |
| 2024-09-05 | 開始されました | H.C. Wainwright | Neutral |
| 2023-12-11 | 再開されました | Goldman | Sell |
| 2023-11-17 | アップグレード | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | ダウングレード | UBS | Buy → Neutral |
| 2023-07-25 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-07-24 | ダウングレード | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | ダウングレード | Jefferies | Buy → Hold |
| 2022-11-15 | 開始されました | CapitalOne | Overweight |
| 2022-08-02 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-02-24 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2022-02-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | ROTH Capital | Neutral → Buy |
| 2021-03-12 | 開始されました | Evercore ISI | Outperform |
| 2021-03-01 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2021-02-17 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2021-01-25 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-12-16 | 開始されました | UBS | Buy |
| 2020-12-11 | 開始されました | Citigroup | Neutral |
| 2020-11-30 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-11-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | ダウングレード | Goldman | Buy → Neutral |
| 2020-03-31 | 開始されました | BMO Capital Markets | Outperform |
| 2020-03-03 | 開始されました | Goldman | Buy |
| 2020-02-18 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2020-02-06 | 開始されました | SunTrust | Buy |
| 2020-01-08 | 開始されました | ROTH Capital | Buy |
| 2020-01-03 | 開始されました | Jefferies | Buy |
| 2019-12-24 | 開始されました | JP Morgan | Overweight |
| 2019-10-15 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-02-20 | 開始されました | Chardan Capital Markets | Buy |
| 2018-10-29 | 開始されました | Barclays | Overweight |
| 2018-10-29 | 開始されました | BofA/Merrill | Buy |
| 2018-10-29 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Kodiak Sciences Inc (KOD) 最新ニュース
HC Wainwright Predicts Kodiak Sciences FY2030 Earnings - MarketBeat
Kodiak Sciences Reaches Analyst Target Price - Nasdaq
Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright By Investing.com - Investing.com Nigeria
Kodiak Sciences stock price target raised to $38 from $26 at H.C. Wainwright - Investing.com Nigeria
KOD: Analyst Raises Price Target to $38 with Buy Rating | KOD St - GuruFocus
Kodiak Sciences Is Riding A 325% Run Into Big Retina Readouts - Finimize
Aug Weekly: Is Kodiak Sciences Inc exposed to currency risksStop Loss & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Why Kodiak Sciences Inc. stock is in analyst buy zoneMarket Performance Report & Technical Analysis for Trade Confirmation - bollywoodhelpline.com
Chart Watch: Can Kodiak Sciences Inc lead its sector in growthJuly 2025 Technicals & Entry Point Confirmation Alerts - baoquankhu1.vn
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Update - MarketBeat
First Week of December 18th Options Trading For Kodiak Sciences (KOD) - Nasdaq
Kodiak Sciences (KOD) Price Target Increased by 24.19% to 28.05 - Nasdaq
Is Kodiak Sciences Inc. (K27) stock included in top ETFsStock Screening Results & Exceptional Growth Portfolio - bollywoodhelpline.com
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 7.7%Here's What Happened - MarketBeat
Hedge Fund Bets: Will Kodiak Sciences Inc benefit from seasonalityRate Hike & Safe Entry Momentum Tips - baoquankhu1.vn
Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? - Yahoo Finance
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Kodiak Sciences (KOD) price target increased by 19.36% to 21.71 - MSN
How analysts rate Kodiak Sciences Inc. stock todayQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - ulpravda.ru
Kodiak Sciences (NASDAQ:KOD) Rating Increased to Strong-Buy at UBS Group - MarketBeat
Is Kodiak Sciences Inc. (K27) stock inflation resilient2025 Stock Rankings & Momentum Based Trading Signals - Улправда
Will Kodiak Sciences Inc. stock outperform value stocksTake Profit & Accurate Entry/Exit Alerts - ulpravda.ru
Is Kodiak Sciences (KOD) Pricing Reflect Recent Biotech Pipeline And Funding Developments Accurately - Sahm
Is Kodiak Sciences Inc. stock safe for conservative investorsWatch List & AI Powered Trade Plan Recommendations - Улправда
Can Kodiak Sciences Inc. stock weather global recessionJuly 2025 Institutional & Fast Moving Stock Trade Plans - Улправда
Is Kodiak Sciences Inc. (K27) stock ideal for retirement investors2025 EndofYear Setup & Risk Managed Investment Entry Signals - ulpravda.ru
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference - MEXC
Retina biotech Kodiak Sciences to present at major J.P. Morgan event - Stock Titan
UBS Initiates Coverage of Kodiak Sciences (KOD) with Buy Recommendation - Nasdaq
KOD: UBS Initiates Coverage with 'Buy' Rating and $50 Price Targ - GuruFocus
UBS initiates Kodiak Sciences stock with Buy rating, $50 price target By Investing.com - Investing.com South Africa
UBS initiates Kodiak Sciences stock with Buy rating, $50 price target - Investing.com Australia
PRN_FinancialWrapper | PR NewswireKodiak Sciences IncCommon Stock (Nasdaq:KOD) Detailed Stock Data - FinancialContent
Kodiak Sciences launches public offering of 6 mln shares - MSN
Volume Recap: Why GeneDx Holdings Corp Equity Warrant stock is rated strong buy - moha.gov.vn
Will Kodiak Sciences Inc stock outperform value stocksProfit Target & Long Hold Capital Preservation Plans - moha.gov.vn
Is Kodiak Sciences Inc a good long term investmentInsider Selling Patterns & Low Entry Investment Ideas - Early Times
Kodiak Sciences Inc Stock Analysis and ForecastPrice Action Trading & Exceptional Capital Investment - earlytimes.in
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.8%Here's Why - MarketBeat
The Biggest IPO of the Year Prompts Huge Insider Buy - AOL.com
Investors Buy Big as Medline’s IPO Raises Over $6 Billion - cointurk finance
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.8%Here's Why - MarketBeat
Kodiak Sciences stock hits 52-week high at $29.52 By Investing.com - Investing.com Australia
Kodiak Sciences Stock Surge: An In-Depth Look - timothysykes.com
Kodiak Sciences (NASDAQ:KOD) Shares Up 6%Here's Why - MarketBeat
Kodiak Sciences stock hits 52-week high at $29.52 - Investing.com
Kodiak Sciences (NASDAQ:KOD) Hits New 52-Week HighWhat's Next? - MarketBeat
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025 - Finviz
Kodiak Sciences (NASDAQ:KOD) Shares Gap Up After Insider Buying Activity - MarketBeat
Kodiak Sciences Inc (KOD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):